| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 2, 2026 | Sell(S) | 17K | $7.45 | $124K | 1.2M |
| Jan 31, 2026 | Tax withholding(F) | 47K | $7.36 | $345K | 1.3M |
| Jan 31, 2026 | Tax withholding(F) | 24K | $7.36 | $179K | 1.3M |
| Jan 31, 2026 | Tax withholding(F) | 98K | $7.36 | $724K | 1.3M |
| Jan 30, 2026 | Grant(A) | 121K | — | $0 | 1.4M |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jan 30, 2026 | Grant(A) | 162K | — | $0 | 162K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001652410-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Xeris Biopharma Holdings, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001652410-26-000004"
Use Arkolith to summarize insider buying and selling at Xeris Biopharma Holdings, Inc. over the last 90 days and cite the filings.